A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication in vivo
Despite unprecedented efforts, our therapeutic arsenal against SARS-CoV-2 remains
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
[HTML][HTML] A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo
Despite unprecedented efforts, our therapeutic arsenal against SARS-CoV-2 remains
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
[PDF][PDF] A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo Taha Y. Taha, Rahul K …
NJ Martinez-Sobrido, A Ashworth, JS Fraser, M Ott… - scienceopen.com
Despite unprecedented efforts, our therapeutic arsenal against SARS-CoV-2 remains
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
[PDF][PDF] A single inactivating amino acid change in the SARS-CoV-2 NSP3 Mac1 domain attenuates viral replication and pathogenesis in vivo Taha Y. Taha, Rahul K …
NJ Sobrido, A Ashworth, JS Fraser, M Ott, M Ott - scienceopen.com
Despite unprecedented efforts, our therapeutic arsenal against SARS-CoV-2 remains
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …
limited. The conserved macrodomain 1 (Mac1) in NSP3 is an enzyme exhibiting ADP …